TOP PICK
Diagnocure Inc.
Has a test on the market for bladder testing for cancer. Now working with a US company, Gen-Probe, to develop a prostrate diagnostic test for the US and world markets. Tests are 90% accurate compared to the PSA tests which are only right once out of four times. Have also just announced testing for lung cancer with high accuracy figures.
biotechnology / pharmaceutical
Showing 1 to 1 of 1 entries
  • «
  • 1
  • »

Diagnocure Inc.(CUR-T) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Diagnocure Inc. is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Diagnocure Inc.(CUR-T) Frequently Asked Questions

What is Diagnocure Inc. stock symbol?

Diagnocure Inc. is a OTC stock, trading under the symbol CUR-T on the (). It is usually referred to as or CUR-T

Is Diagnocure Inc. a buy or a sell?

In the last year, there was no coverage of Diagnocure Inc. published on Stockchase.

Is Diagnocure Inc. a good investment or a top pick?

Diagnocure Inc. was recommended as a Top Pick by on . Read the latest stock experts ratings for Diagnocure Inc..

Why is Diagnocure Inc. stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Diagnocure Inc. worth watching?

In the last year, there was no coverage of Diagnocure Inc. published on Stockchase.

What is Diagnocure Inc. stock price?

On , Diagnocure Inc. (CUR-T) stock closed at a price of $.